Key Highlights
•
The drug tofacitinib can repair both inflammation and mitochondrial problems in specific immune cells from rheumatoid arthritis patients. This finding suggests a new way to treat autoimmune diseases by targeting the cell’s energy source.
Source →
•
A pilot study suggests that the muscle-wasting disease FSHD may be linked to a higher chance of also having the autoimmune condition myasthenia gravis. This novel association could change how doctors screen for and manage these rare diseases together.
Source →
•
Removing the thymus gland in newborn mice reveals how early changes in this organ can lead to autoimmune disease by weakening a crucial type of “peacekeeper” immune cell. This research helps explain the origins of autoimmune conditions like Sjögren’s syndrome.
Source →
•
A child’s brain tumor and congenital kidney defect were linked to two specific genetic variants, one in the KMT2D gene, which is important for development. This case highlights how combinations of subtle genetic changes can contribute to complex health problems.
Source →
Stay curious. Stay informed — with
Science Briefing.
This is a one time Briefing, Upgrade to continue.
